Style | Citing Format |
---|---|
MLA | Javarsiani MH, Javanmard SH, Sajedianfard J. "Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin." Current Cancer Therapy Reviews, vol. 18, no. 2, 2022, pp. 118-122. |
APA | Javarsiani MH, Javanmard SH, Sajedianfard J (2022). Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin. Current Cancer Therapy Reviews, 18(2), 118-122. |
Chicago | Javarsiani MH, Javanmard SH, Sajedianfard J. "Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin." Current Cancer Therapy Reviews 18, no. 2 (2022): 118-122. |
Harvard | Javarsiani MH, Javanmard SH, Sajedianfard J (2022) 'Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin', Current Cancer Therapy Reviews, 18(2), pp. 118-122. |
Vancouver | Javarsiani MH, Javanmard SH, Sajedianfard J. Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin. Current Cancer Therapy Reviews. 2022;18(2):118-122. |
BibTex | @article{ author = {Javarsiani MH and Javanmard SH and Sajedianfard J}, title = {Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin}, journal = {Current Cancer Therapy Reviews}, volume = {18}, number = {2}, pages = {118-122}, year = {2022} } |
RIS | TY - JOUR AU - Javarsiani MH AU - Javanmard SH AU - Sajedianfard J TI - Expression of Mtor/70S6k Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin JO - Current Cancer Therapy Reviews VL - 18 IS - 2 SP - 118 EP - 122 PY - 2022 ER - |